|
|
||||||||
1-Adrenergic and cholinergic agonists activate
MAPK by separate mechanisms to inhibit secretion in lacrimal
gland
1 Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114; and 2 Department of Ophthalmology, Asahikawa Medical College, Asahikawa 078-8510, Japan
The
purpose of this study was to determine the role of p42/p44
mitogen-activated protein kinase (MAPK) in
1-adrenergically and cholinergically stimulated protein
secretion in rat lacrimal gland acinar cells and the pathways used by
these agonists to activate MAPK. Acini were isolated by collagenase
digestion and incubated with the
1-adrenergic agonist
phenylephrine or the cholinergic agonist carbachol, and activation of
MAPK and protein secretion were then measured. Phenylephrine and
carbachol activated MAPK in a time- and concentration-dependent manner.
Inhibition of MAPK significantly increased phenylephrine- and
carbachol-induced protein secretion. Inhibition of EGF receptor (EGFR)
with AG1478, an inhibitor of the EGFR tyrosine kinase activity,
significantly increased phenylephrine- but not carbachol-induced
protein secretion. Whereas phenylephrine-induced activation of MAPK was
completely inhibited by AG1478, activation of MAPK by carbachol was
not. Phenylephrine stimulated tyrosine phosphorylation of the EGFR, whereas carbachol stimulated p60Src, and possibly Pyk2, to
activate MAPK. We conclude that, in the lacrimal gland, activation of
MAPK plays an inhibitory role in
1-adrenergically and
cholinergically stimulated protein secretion and that these agonists
use different signaling mechanisms to activate MAPK.
signal transduction; Pyk2; Src
This article has been cited by other articles:
![]() |
M. A. Shatos, J. Gu, R. R. Hodges, K. Lashkari, and D. A. Dartt ERK/p44p42 Mitogen-Activated Protein Kinase Mediates EGF-Stimulated Proliferation of Conjunctival Goblet Cells in Culture Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3351 - 3359. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Funaki, R. R. Hodges, and D. A. Dartt Role of cAMP inhibition of p44/p42 mitogen-activated protein kinase in potentiation of protein secretion in rat lacrimal gland Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1551 - C1560. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Snider and K. E. Meier Receptor transactivation cascades. Focus on "Effects of {alpha}1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells" Am J Physiol Cell Physiol, January 1, 2007; 292(1): C1 - C3. [Full Text] [PDF] |
||||
![]() |
L. Chen, R. R. Hodges, C. Funaki, D. Zoukhri, R. J. Gaivin, D. M. Perez, and D. A. Dartt Effects of {alpha}1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells Am J Physiol Cell Physiol, November 1, 2006; 291(5): C946 - C956. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Hodges, J. D. Rios, J. Vrouvlianis, I. Ota, D. Zoukhri, and D. A. Dartt Roles of Protein Kinase C, Ca2+, Pyk2, and c-Src in Agonist Activation of Rat Lacrimal Gland p42/p44 MAPK. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3352 - 3359. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Tepavcevic, R. R. Hodges, D. Zoukhri, and D. A. Dartt Signal Transduction Pathways Used by EGF to Stimulate Protein Secretion in Rat Lacrimal Gland Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1075 - 1081. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |